Myconolak (Amorolfine Hydrochloride)

Amorolfine Hydrochloride, the active ingredient in Myconolak, is an antifungal presented as a topical solution for external use. It is indicated for the treatment of fungal nail infections and superficial skin fungal conditions in adults.

GNH USA supplies Myconolak as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Clients benefit from reliable logistics, comprehensive documentation, and responsive technical support throughout the procurement process.

Myconolak, containing the antifungal Amorolfine Hydrochloride, is used to treat infections caused by dermatophytes and yeasts affecting nails and skin.

- Onychomycosis: reduces fungal growth and improves nail appearance. - Tinea pedis (athlete's foot): relieves itching and clears skin infection. - Tinea corporis (ringworm): eliminates the dermatophyte and promotes lesion healing. - Tinea cruris (jock itch): controls fungal proliferation and reduces irritation. - Candida‑related intertrigo: diminishes yeast colonization and eases redness.

Topical application of Myconolak may be associated with local skin reactions, most of which are mild and transient.

Common Side Effects: - Mild burning sensation: transient feeling of heat at the application site. - Itching: occasional pruritus following use. - Redness: mild erythema of the treated area.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe rash, swelling, or blistering requiring medical attention. - Severe skin irritation: intense burning, pain, or ulceration. - Secondary bacterial infection: signs of infection such as pus or increased warmth.

Before using Myconolak, consider the following safety measures. - Apply to clean, dry skin: ensure the area is free of debris before use. - Avoid use on broken or inflamed skin: may increase irritation. - Do not combine with other topical antifungals unless directed: risk of additive irritation. - Discontinue if severe reaction occurs: seek medical advice promptly. - Store at room temperature: keep in the original container, protect from light and moisture.

Myconolak may interact with other topical or systemic agents; review the following.

Major Interactions (Avoid): - Concurrent use with topical corticosteroids: may mask irritation and increase risk of adverse skin reactions. - Application with acidic skin products (e.g., salicylic acid): can cause severe dermatitis. - Use together with systemic antifungals (e.g., itraconazole): may increase systemic exposure, though unlikely with topical use.

Moderate Interactions (Monitor Closely): - Co‑application with moisturizers: may alter drug absorption, monitor efficacy. - Use under occlusive dressings: can raise local concentration, watch for irritation. - Combination with phototherapy: may enhance photosensitivity, observe skin response.